MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 280 filers reported holding MYRIAD GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,997,000 | -20.3% | 65,256 | -11.4% | 0.14% | +11.4% |
| Q4 2014 | $2,507,000 | -19.2% | 73,616 | -8.5% | 0.12% | -19.6% |
| Q3 2014 | $3,104,000 | +11.1% | 80,476 | +12.1% | 0.15% | -5.6% |
| Q2 2014 | $2,794,000 | +14.2% | 71,778 | +0.3% | 0.16% | +1.2% |
| Q1 2014 | $2,447,000 | +23.5% | 71,576 | -24.2% | 0.16% | +28.0% |
| Q4 2013 | $1,982,000 | -32.5% | 94,466 | -24.4% | 0.12% | -37.5% |
| Q3 2013 | $2,936,000 | – | 124,941 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |